The ankyrin 3 gene (ANK3) is a well-established risk gene for psychiatric illness, but the mechanisms underlying its pathophysiology remain elusive. We examined the molecular effects of disrupting brain-specific Ank3 isoforms in mouse and neuronal model systems. RNA sequencing of hippocampus from Ank3+/-and Ank3+/+ mice identified altered expression of 282 genes that were enriched for microtubule-related functions. Results were supported by increased expression of microtubule end-binding protein 3 (EB3), an indicator of microtubule dynamics, in Ank3+/-mouse hippocampus. Live-cell imaging of EB3 movement in primary neurons from Ank3+/-mice revealed impaired elongation of microtubules. Using a CRISPRdCas9-KRAB transcriptional repressor in mouse neuro-2a cells, we determined that repression of brain-specific Ank3 increased EB3 expression, decreased tubulin acetylation, and increased the soluble:polymerized tubulin ratio, indicating enhanced microtubule dynamics. These changes were rescued by inhibition of glycogen synthase kinase 3 (GSK3) with lithium or CHIR99021, a highly selective GSK3 inhibitor. Brain-specific Ank3 repression in neuro-2a cells increased GSK3 activity (reduced inhibitory phosphorylation) and elevated collapsin response mediator protein 2 (CRMP2) phosphorylation, a known GSK3 substrate and microtubule-binding protein. Pharmacological inhibition of CRMP2 activity attenuated the rescue of EB3 expression and tubulin polymerization in Ank3 repressed cells by lithium or CHIR99021, suggesting microtubule instability induced by Ank3 repression is dependent on CRMP2 activity. Taken together, our data indicate that ANK3 functions in neuronal microtubule dynamics through GSK3 and its downstream substrate CRMP2. These findings reveal cellular and molecular mechanisms underlying brain-specific ANK3 disruption that may be related to its role in psychiatric illness.All rights reserved. No reuse allowed without permission.(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint . http://dx.doi.org/10.1101/303990 doi: bioRxiv preprint first posted online Apr. 21, 2018; 3 Introduction Large-scale genomic studies are providing a clearer picture of the genetic architecture of psychiatric illness. Genetic variation in ANK3 is associated with several psychiatric disorders, including bipolar disorder (BD) and autism spectrum disorders (ASD). [1][2][3][4][5][6][7][8][9][10][11] Human postmortem brain studies demonstrate that carriers of ANK3 alleles associated with BD have lower ANK3 expression at the transcript and protein levels, 12,13 suggesting that decreased expression of ANK3 contributes to disease. Despite strong genetic evidence that ANK3 contributes to psychiatric illness 14 , the precise mechanism is unknown. ANK3 encodes the ankyrin-G scaffolding protein that anchors integral membrane proteins to the cytoskeleton. 15,16 There are several protein isoforms of ankyrin-G due to alternative splicing a...